Life Sciences Archives - Page 19 of 21 - Becker's Hospital Review

Mark Cuban seeks independent pharmacists | Amazon acquires One Medical for $3.9B | Fujifilm Irvine Scientific sued over recalled embryo culture oil | How AI can speed up drug development | 7 US healthcare billionaires

February 22, 2023 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. Couple sues Fujifilm Irvine Scientific over recalled embryo culture oil Full story 2. Amazon completes $3.9B acquisition of One Medical Full story 3. Mark Cuban's low-cost pharmacy to partner with independent…

HHS unveils 3 new drug price models | Walmart, drugmakers face eye drop suits | Northwell exec weighs in on NY masking requirements | Va. invests $67M in biotech | 11 cities hit hardest by inflation

February 15, 2023 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. HHS unveils 3 new drug price models Full story 2. 11 cities hit hardest by inflation Full story 3. Walmart faces suits over eye drops that allegedly killed 1, blinded 5 Full…

Teva exits PhRMA | CVS, Oak Street strike $10.6B deal | Former Google CEO to serve on federal biotech commission | State of the Union: 10 healthcare notes | Pharmacist among those arrested in $1.5M pill mill case

February 8, 2023 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. Following AbbVie's steps, Teva leaves PhRMA Full story 2. Biden's State of the Union: 10 healthcare takeaways Full story 3. Pharmacist, 8 others arrested in $1.5M pill mill case Full story 4. Across…

Humira's 1st biosimilar enters market | PHE to end May 11 | Pfizer invests $25M in biotech co. | Nurses asked to give up licenses amid fake degree scheme | $290M life sciences facility gets green light

February 1, 2023 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. 1st Humira biosimilar enters market with two prices Full story 2. Biden administration to end COVID-19 public health emergency in May Full story 3. Pfizer invests $25M in biotech company Full story…

Amazon kicks off monthly script service | Kroger's 1st personalized medicine trial | Digital life sciences VC fund launches with $350M | Meet Mark Cuban's 3 PBM partners | 20 systems spending the most on contract labor

January 25, 2023 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. Amazon rolls out RxPass prescription service for $5 per month Full story 2. 20 health systems with highest contract labor expenses Full story 3. Meet the 3 PBMs partnered with Mark…

Drug researcher gets 3 years in prison for asthma drug study lie | Heparin shortage drags on | Cleveland Clinic expects $200M loss | Biotech investment to bounce back | Top 50 hospitals: Healthgrades

January 18, 2023 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. Drug researcher sentenced to 3 years in prison for lying about asthma drug study Full story 2. Healthgrades' 50 top hospitals for 2023 Full story 3. 6 drugmakers are short on…

Life science investors to ramp up M&A activity | 3rd Alzheimer's drug approved | Healthcare at its worst: 10 Shkreli awardees | 5 J&J investments | Sexual assault claims spur Cleveland Clinic probe

January 11, 2023 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. FDA approves 3rd Alzheimer's drug Full story 2. 10 healthcare names get Shkreli Awards for bad behavior Full story 3. 60% of life science investors look to increase M&A activity in…

House blames FDA, Biogen for Aduhelm fail | Biotech investments slowed in 2022 | 2 biotech CEOs charged in alleged fraud | Viatris acquires 2 life sciences cos. | Strike set at NYC hospitals

January 4, 2023 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. Federal investigation blames FDA, Biogen for Aduhelm scandal Full story 2. Strike set at 7 NYC hospitals Full story 3. Investment in health and biotech companies cooled to $90B in 2022 Full…

Can health systems compete with CVS, Walgreens? | AbbVie exits 2 pharma lobbies | $1.7T omnibus bill: 8 healthcare takeaways | Labcorp opens LA lab | HHS unlocks Tamiflu

December 21, 2022 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. Can health systems compete with disruption from CVS, Walgreens? Full story 2. Congress' last-minute $1.7 trillion omnibus package: 8 healthcare takeaways Full story 3. AbbVie leaves 2 pharmaceutical lobbies Full story 4. Health…

Amgen snags Horizon in $27.8B deal | Top 10 pharma cos. by revenue | Inmate shot, killed in Texas hospital | Syndax issues $150M public offering pricing | Flu activity by state

December 14, 2022 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. 2022's priciest healthcare acquisition: Amgen to buy Horizon for $27.8B Full story 2. Flu activity, state by state Full story 3. Top 10 pharma companies by 2021 revenue Full story 4. The average…